CN110551783A - Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter - Google Patents

Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter Download PDF

Info

Publication number
CN110551783A
CN110551783A CN201910901442.6A CN201910901442A CN110551783A CN 110551783 A CN110551783 A CN 110551783A CN 201910901442 A CN201910901442 A CN 201910901442A CN 110551783 A CN110551783 A CN 110551783A
Authority
CN
China
Prior art keywords
fermentation
parts
feeding
oxygen consumption
consumption rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910901442.6A
Other languages
Chinese (zh)
Other versions
CN110551783B (en
Inventor
李敏超
张嗣良
庄英萍
储炬
杭海峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Institute Of Innovation East China University Of Technology
East China University of Science and Technology
Original Assignee
Qingdao Institute Of Innovation East China University Of Technology
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Institute Of Innovation East China University Of Technology, East China University of Science and Technology filed Critical Qingdao Institute Of Innovation East China University Of Technology
Priority to CN201910901442.6A priority Critical patent/CN110551783B/en
Publication of CN110551783A publication Critical patent/CN110551783A/en
Application granted granted Critical
Publication of CN110551783B publication Critical patent/CN110551783B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/46Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
    • C12P19/48Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin
    • C12P19/485Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a fermentation method for producing gentamicin by continuous fed-batch with oxygen consumption rate as a key control parameter, which comprises a primary seed preparation process, a secondary seed preparation process and a fermentation production process, wherein in the fermentation production process, the purpose of regulating and controlling the oxygen consumption rate is realized by accurately controlling the sugar supplement rate or the nitrogen supplement rate in the fermentation process, when the OUR in the early stage of the fermentation process is reduced from a peak to a target OUR, the feeding is started, and the OUR is maintained within the range of 15-30 in the feeding process, so that the metabolic activity of thalli can keep the capability of continuously synthesizing the gentamicin. Compared with the prior art, the method realizes continuous feeding after the OUR in the process is reduced to different OUR from the peak after initial culture and utilization by the continuous feeding, maintains the metabolic activity of thalli, continuously supplements nutrition after entering a secondary metabolic resistance generation stage in the middle and later stages, has stable product synthesis, continuously increases the titer, and has very good continuous resistance generation maintenance. After adopting automatic control, continuous feeding is adopted to maintain OUR, which is convenient for industrial production scale control.

Description

Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter
Technical Field
The invention belongs to the technical field of fermentation, and particularly relates to a fermentation method for producing gentamicin by continuous flow feeding with oxygen consumption rate as a key control parameter.
Background
Gentamicin is a broad-spectrum aminoglycoside antibiotic with independent intellectual property rights and widely applied to agriculture, medicine and feed industries in China; at present, almost half of the global aminoglycoside antibiotics market is occupied, and the annual output value of domestic gentamicin bulk drug market is close to the output value scale of 10 hundred million. Therefore, the method has important social and practical significance for improving the fermentation level and the product quality of gentamicin in China by researching the process technology.
The oxygen demand of the thalli in different fermentation stages is different, and is particularly obvious in the antibiotic fermentation process; the supply of oxygen during fermentation not only directly affects the growth of the microorganisms but also has a major impact on the activity of the enzyme system, metabolic pathways and product yields and their composition during fermentation. Therefore, the research on the influence and control of the oxygen supply on the fermentation has important significance on improving the production efficiency, improving the product quality and the like. In the general Oxygen-consuming fermentation process, higher Oxygen supply is controlled to avoid the Oxygen limitation, the Oxygen supply level is represented by Dissolved Oxygen (DO), and the DO can be effectively controlled by controlling the stirring speed and the air flow. Dissolved oxygen levels are affected by both oxygen supply rate (OTR) and oxygen consumption rate (OUR). Wherein OTR reflects the oxygen supply capacity of the equipment, and the main influencing factors mainly relate to the rheological property and the operating parameters of the fermentation liquid, such as flow, stirring speed, the number of stirring layers, stirring paddle type and the like. While the OUR is obviously different from DO and OTR, as a typical physiological parameter, the OUR reflects the (millimolar) number of oxygen consumed by a unit volume (mass) of fermentation liquor in unit time, and generally the OUR can represent the energy metabolism state of thalli or cells in the fermentation process and can be used as a key parameter for controlling the fermentation process. Currently, some patents report that OUR is adopted as a key parameter for fermentation process control to control the fermentation process of fermentation products and realize high yield (patent number: CN 103642870A, CN 105154490A, CN 108060144A, CN 101560535A, CN 102703540A), but reports that OUR for controlling the fermentation process by continuous feeding realizes optimized control of the gentamicin fermentation process, improves the gentamicin fermentation yield and improves the components of the gentamicin fermentation process are not reported. At present, the actual fermentation unit of gentamicin in China is basically maintained at the fermentation level of 1300-1600 u/ml; the production method basically adopts the fermentation process that the whole materials are supplemented intermittently in a fixed period, the viscosity is generally controlled by adopting a water supplementing mode under the condition of high viscosity after the materials are supplemented, and the fermentation process is relatively simple to control.
Disclosure of Invention
the invention aims to overcome the defects of the prior art and provide a fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate (or oxygen uptake rate, OUR) as a key control parameter. The method can stably improve the fermentation production level and improve various components of gentamicin.
The purpose of the invention can be realized by the following technical scheme:
A fermentation method for producing gentamicin by continuous flow feeding with oxygen consumption rate as key control parameter is a method for producing gentamicin by pure culture and three-stage fermentation of Micromonospora echinospora as an initial strain, and comprises the specific processes of first-stage seed preparation, second-stage seed preparation and fermentation production,
In the fermentation production process, the purpose of regulating and controlling the oxygen consumption rate is realized by accurately controlling the sugar supplement rate or the nitrogen supplement rate in the fermentation process, the feeding is started when the OUR is reduced from a high peak to the target OUR in the early stage of the fermentation process, and the OUR is maintained within the range of 15-30 in the feeding process, so that the metabolic activity of thalli can keep the capacity of continuously synthesizing the gentamicin.
In the fermentation production process, in order to prevent the oxygen concentration in the fermentation process from being lower than the critical oxygen concentration, stirring linkage is adopted, and the dissolved oxygen is controlled to be not lower than 40%.
In the fermentation production process, the fermentation liquor volume control strategy is to discharge 5kg when the fermentation liquor reaches 35kg, then continue to feed after the volume reaches 35 kg.
The rate of oxygen consumption during fermentation decreasing from the pre-fermentation peak to the target OUR is the OUR level at which feed control is prepared.
In one embodiment of the invention, OUR can be controlled in stages, generally from high to low, based on metabolic activity in a fermentative production process.
In one embodiment of the present invention, a preferred case of OUR control is: OUR is maintained at 30-28 for 14-48 h, 28-25 for 48-72 h, and 20-25 for 72-96 h.
In one embodiment of the present invention, the process mass spectrometer BP400 from THERMAL FISHER was used in the fermentation production process to perform off-gas detection and calculate the physiological parameters of the fermentation process OUR based on the "star of fermentation" software package.
The software package of the 'star of fermentation' is composed of a star of fermentation, a fermentation network message and auxiliary software, has the main functions of online acquisition of fermentation process data, online calculation, offline data input, event record input and image input, is mature known operating software, and can be obtained by the national research center of biochemical engineering technology (Shanghai), wherein relevant information of the software can refer to http:// www.doc88.com/p-9943458130154.html and http:// www.nc-bio.com/products/retrieval-projects/352. html.
In one embodiment of the present invention, the OUR feed is controlled in the fermentative production process to be fed with a feed nitrogen medium (g/L) comprising: silkworm chrysalis meal 22, corn steep liquor 30, high-temperature soybean meal 120(100 meshes), citric acid 20, ammonium sulfate 0.76, potassium nitrate 3.8, cobalt chloride 0.004, natural enemy 0.04 and organic silicone oil 0.04; the pH was adjusted to 9.0 using sodium hydroxide before sterilization.
in one embodiment of the invention, the feed sugar composition fed to the OUR is controlled to glucose (500 g/L concentration) in the fermentative production process.
In one embodiment of the present invention, the primary seed medium composition (g/L): 1.4 parts of glucose, 15 parts of corn starch, 20 parts of corn flour, 2.6 parts of Angel peptone, 20 parts of low-temperature soybean flour, 2.5 parts of ammonium sulfate, 0.054 part of potassium nitrate, 6.2 parts of calcium carbonate, 0.03 part of natural sodium nitrite and 0.05 part of silicone oil, wherein the pH value is 7.2;
Secondary seed medium (g/L): corn starch 23, corn flour 30, Angel peptone 13, bean cake powder 13, ammonium sulfate 5, magnesium sulfate 7.1, potassium nitrate 0.5, calcium carbonate 7, cobalt oxide 0.002, sodium chloride 0.05 and silicone oil 0.03, and pH 7.8;
Fermentation basal medium (g/L): 50 parts of corn starch, 20 parts of corn flour, 25 parts of medium-temperature soybean flour, 23 parts of Angel peptone, 5 parts of ammonium sulfate, 7.1 parts of magnesium sulfate, 0.5 part of potassium nitrate, 7 parts of calcium carbonate, 0.002 part of cobalt oxide, 0.05 part of sodium alginate and 0.03 part of organic silicone oil, wherein the pH value is 9.0.
In one embodiment of the present invention, the primary seed culture conditions are: proportioning the components of a first-grade seed culture medium in a 15L seeding tank, sterilizing the first-grade seed culture medium, keeping the pressure of about 0.05MPa by using sterile air, inoculating a cultured shake flask seed solution into the first-grade seeding tank for culture, wherein the culture process comprises the following steps: the liquid loading amount is 10L/25; the inoculation amount is 60 ml; the culture temperature is 35.5 +/-0.5 ℃; the aeration ratio is 1: 1; stirring and rotating speed: 0-30h 200rpm, 30-48h 400rpm, pot pressure: 0.03 to 0.05 MPa; and (3) culture period: 48 h;
The secondary seed culture conditions are as follows: proportioning the components of a secondary seed culture medium in a 30L seeding tank, sterilizing and cooling the secondary seed culture medium, keeping the pressure at about 0.05MPa by using sterile air, then transferring 5L of the primary seed culture medium into the secondary seeding tank for culture, and filling the liquid in the secondary seeding tank by 5L/20L. The culture temperature is 35.5 +/-0.5 ℃; the aeration ratio is 1: 1; stirring speed: 300rpm for 0-10h, 400rpm for 10-20h, 450rpm for 20-30h, tank pressure: 0.03 to 0.05 MPa; and (3) culture period: and (5) 48 h.
The 50L fermentation tank culture conditions were: the materials are fed in a 50L seeding tank according to the proportion of a fermentation basic culture medium (the material is 20 kg). Sterilizing the culture medium, cooling, transferring 10kg of the secondary seed solution into a fermentation tank, and culturing. The whole culture temperature is 35.5 +/-0.5 ℃, and the aeration ratio is 1: 1; adjusting the stirring speed according to dissolved oxygen content not less than 30%, and adjusting the tank pressure: 0.03 to 0.05 MPa; and (3) culture period: and (6) 96 h.
The invention realizes the adjustment of the metabolic activity of the thalli by controlling the material supplementing rate, and achieves the purpose of controlling the OUR.
Compared with the prior art, the invention has the following advantages and beneficial effects:
1. Compared with the conventional multiple-time feeding mode, the method has the advantages that continuous feeding is started after the OUR in the process is reduced from the peak after initial culture and utilization through the continuous feeding, the metabolic activity of thalli is maintained, nutrition is continuously supplemented after the secondary metabolic resistance generation stage is started in the middle and later stages, the product synthesis is stable, the titer is continuously increased, and the continuous production resistance is well maintained. After adopting automatic control, continuous feeding is adopted to maintain OUR, which is convenient for industrial production scale control.
2. The invention can realize the adjustment of component proportion by controlling different OUR during continuous material feeding, and is beneficial to the control of product quality. Particularly, according to the actual industrialized production requirement, OUR in different stages can be controlled to realize different component proportions, the content of C1a is obviously improved under the condition of lower OUR, and part of C1a can be extracted from gentamicin products, for example, C1 can reach more than 25% when proper OUR is maintained at about 22-23. The method has good operability, and the product quality can meet the requirements of pharmacopeia on gentamicin components or improve the component proportion according to the actual component requirements of industrial production.
Detailed Description
The present invention will be described in detail with reference to specific examples.
Example 1
The strain used in this example was Micromonospora echinospora, a mature commercial strain.
The whole fermentation process route is as follows: shake flask seed → primary seed culture → secondary seed culture → fermentation culture.
The culture medium comprises the following components:
Primary seed medium (g/L): 1.4 parts of glucose, 15 parts of corn starch, 20 parts of corn flour, 2.6 parts of Angel peptone, 20 parts of low-temperature soybean flour, 2.5 parts of ammonium sulfate, 0.054 parts of potassium nitrate, 6.2 parts of calcium carbonate, 0.03 parts of natural enemy, and 0.05 part of silicone oil with the pH value of 7.2.
Secondary seed medium (g/L): corn starch 23, corn flour 30, Angel peptone 13, bean cake powder 13, ammonium sulfate 5, magnesium sulfate 7.1, potassium nitrate 0.5, calcium carbonate 7, cobalt oxide 0.002, sodium chloride 0.05 and silicone oil 0.03, pH 7.8
Fermentation basal medium (g/L): 50 parts of corn starch, 20 parts of corn flour, 25 parts of medium-temperature soybean flour, 23 parts of Angel peptone, 5 parts of ammonium sulfate, 7.1 parts of magnesium sulfate, 0.5 part of potassium nitrate, 7 parts of calcium carbonate, 0.002 part of cobalt oxide, 0.05 part of sodium alginate and 0.03 part of organic silicone oil, wherein the pH value is 9.0
Feed nitrogen medium (g/L) composition: silkworm chrysalis meal 22, corn steep liquor 30, high-temperature bean flour 120(100 meshes), citric acid 20, ammonium sulfate 0.76, potassium nitrate 3.8, cobalt chloride 0.004, natural enemy 0.04 and organic silicone oil 0.04; the pH was adjusted to 9.0 using sodium hydroxide prior to sterilization.
The sugar supplement composition is as follows: the glucose concentration was 500 g/L.
The culture conditions in the fermentation process are as follows:
First-order seed culture: the mixture ratio is carried out in a 15L seeding tank according to the components of the first-class seed culture medium. Sterilizing a first-stage seed culture medium, keeping the pressure at about 0.05MPa by using sterile air, and then inoculating a cultured shake flask seed solution into a first-stage seed tank for culture, wherein the liquid loading amount is 10L/25 in the culture process; the inoculation amount is 60 ml; the culture temperature is 35.5 +/-0.5 ℃; the aeration ratio is 1: 1; stirring speed: 0-30h 200rpm, 30-48h 400rpm, pot pressure: 0.03 to 0.05 MPa; and (3) culture period: and (5) 48 h.
Secondary seed culture: proportioning according to the components of the secondary seed culture medium in a 30L seeding tank. Sterilizing the secondary seed culture medium, cooling, maintaining the pressure at 0.05MPa with sterile air, culturing the primary seed to obtain 5L, transferring into a secondary seed tank, and culturing to obtain 5L/20L liquid. The culture temperature is 35.5 +/-0.5 ℃; the aeration ratio is 1: 1; stirring speed: 300rpm for 0-10h, 400rpm for 10-20h, 450rpm for 20-30h, tank pressure: 0.03 to 0.05 MPa; and (3) culture period: and (5) 48 h.
50L fermentation tank culture: the materials are fed in a 50L seeding tank according to the proportion of a fermentation basic culture medium (the material is 20 kg). Sterilizing the culture medium, cooling, transferring 10kg of the secondary seed solution into a fermentation tank, and culturing. The whole culture temperature is 35.5 +/-0.5 ℃, and the aeration ratio is 1: 1; adjusting the stirring speed according to dissolved oxygen content not less than 30%, and adjusting the tank pressure: 0.03 to 0.05 MPa; and (3) culture period: and (6) 96 h.
And (3) a feeding control strategy: according to the OUR reduction to 32mmol/kg/h before OUR fermentation, sugar and nitrogen supplement are started, and the OUR is maintained within the range of 28-30 during the fermentation process. The volume is controlled to be 30-35kg according to the weighing of the fermentation tank, and 5kg is discharged when the volume reaches about 35 kg.
After the fermentation process is finished, the relevant indexes of the fermentation liquor are measured and analyzed, and the fermentation efficiency of the result is 2884 ug/ml.
Example 2
the primary seed culture and the secondary seed culture were the same as in example 1, and the primary seed culture medium, the secondary seed culture medium and the fermentation medium were the same as in example 1, except for the OUR of the continuous feed control. And (3) a feeding control strategy: according to the OUR reduction to about 22mmol/kg/h in the earlier stage of OUR fermentation, sugar and nitrogen are supplemented, and the OUR is maintained within the range of 18-20 in the fermentation process. The volume is controlled to be 30-35kg according to the weighing of the fermentation tank, and 5kg of materials is discharged when the volume reaches about 35 kg.
Example 3
The primary seed culture and the secondary seed culture were the same as in example 1, and the primary seed culture medium, the secondary seed culture medium and the fermentation medium were the same as in example 1, except for the OUR of the continuous feed control. And (3) a feeding control strategy: according to the OUR reduction to about 28mmol/kg/h in the earlier stage of OUR fermentation, sugar and nitrogen are supplemented, and the OUR is maintained within the range of 22-25 in the fermentation process. The volume is controlled to be 30-35kg according to the weighing of the fermentation tank, and 5kg of materials is discharged when the volume reaches about 35 kg.
Example 4
The primary seed culture and the secondary seed culture were the same as in example 1, and the primary seed culture medium, the secondary seed culture medium and the fermentation medium were the same as in example 1, except for the OUR of the continuous feed control. And (3) a feeding control strategy: according to the OUR in the earlier stage of OUR fermentation, when the OUR is reduced to about 32mmol/kg/h, sugar and nitrogen are supplemented, the OUR is maintained at 30-28 within 14-48 hOUR, 28-25 within 48-72 h, and the OUR is maintained at 20-25 within 72-tank discharge. The volume is controlled to be 30-35kg according to the weighing of the fermentation tank, and 5kg is discharged when about 35kg is reached.
The results of the 4 examples are shown in the table, and the requirements (Chinese pharmacopoeia C1: 25-50%, C1a 15-40%, C2+ C2a 20-50%, English pharmacopoeia C1: 25-50%, C1a 10-35%, C2+ C2a 25-55%) on the ratio of the components of gentamycin specified by Chinese pharmacopoeia and English pharmacopoeia are compared, so that the final product concentration of high OUR in the fermentation process in example 1 can be maintained to be 2884ug/ml, the belt release amount of 65% is reached, the single-tank capacity is maximum, and the C1 in the only defect component ratio can not reach the standard. In example 2, the lower OUR in the maintenance process obviously shows that the C1a component is greatly improved, and the extraction part C1a can meet the market demand through the process control. Maintaining an intermediate OUR level in example 3 can achieve higher fermentation units in the fermentation process, with more suitable component ratios. In example 4, a phased OUR control strategy is adopted, which can give consideration to the effects of high yield and component improvement in adjusting the fermentation unit and component ratio, and is an optimal control scheme.
TABLE 1 results of four examples
the implementation cases in the present specification are described in a progressive manner, each implementation case is mainly described as different from other embodiments, and the same and similar parts in the implementation cases are referred to each other.
The invention is not limited to four examples, and the improvement of components or the improvement of fermentation titer by the similar process strategy of the invention is within the protection scope of the invention.
The embodiments described above are described to facilitate an understanding and appreciation of the invention by those skilled in the art. It will be readily apparent to those skilled in the art that various modifications to these embodiments may be made, and the generic principles described herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above embodiments, and those skilled in the art should make modifications and alterations without departing from the scope of the present invention.

Claims (10)

1. A fermentation method for producing gentamicin by continuous flow feeding with oxygen consumption rate as key control parameter is characterized by comprising a first-stage seed preparation process, a second-stage seed preparation process and a fermentation production process,
In the fermentation production process, the purpose of regulating and controlling the oxygen consumption rate is realized by accurately controlling the sugar supplement rate or the nitrogen supplement rate in the fermentation process, the feeding is started when the OUR is reduced from a high peak to the target OUR in the early stage of the fermentation process, and the OUR is maintained within the range of 15-30 in the feeding process, so that the metabolic activity of thalli can keep the capacity of continuously synthesizing the gentamicin.
2. The fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as a key control parameter according to claim 1, wherein in the fermentation production process, stirring linkage is adopted, and dissolved oxygen is controlled to be not less than 40%.
3. The fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as key control parameter as claimed in claim 1, wherein in the fermentation production process, the fermentation broth volume control strategy is to discharge 5kg when the fermentation broth reaches 35kg, then continue feeding after the volume reaches 35 kg.
4. The fermentation process of claim 1, wherein the decrease in oxygen consumption rate from the pre-fermentation peak to the target OUR during fermentation is the OUR level for which feed control is prepared.
5. the fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as key control parameter as claimed in claim 1, wherein OUR is controlled in stages according to metabolic activity in the fermentation production process to decrease from high to low.
6. A fermentation process for the production of gentamicin by continuous fed batch with oxygen consumption rate as the key control parameter as claimed in claim 5 wherein one way of OUR control is: OUR is maintained at 30-28 for 14-48 h, 28-25 for 48-72 h, and 20-25 for 72-96 h.
7. The fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as key control parameter as claimed in claim 1, wherein in the fermentation production process, a process mass spectrometer BP400 of THERMAL FISHER company is used, and the detection of tail gas and the calculation of OUR physiological parameters of the fermentation process are realized based on a software package of fermentation Star.
8. The fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as key control parameter as claimed in claim 1, wherein in the fermentation production process, the feeding nitrogen culture medium (g/L) for controlling OUR feeding is: silkworm chrysalis meal 22, corn steep liquor 30, high-temperature bean flour 120, citric acid 20, ammonium sulfate 0.76, potassium nitrate 3.8, cobalt chloride 0.004, natural enemy 0.04 and organic silicone oil 0.04; the pH was adjusted to 9.0 using sodium hydroxide prior to sterilization.
9. The fermentation process for the production of gentamicin by continuous fed batch with oxygen consumption rate as key control parameter as claimed in claim 1, wherein the feed sugar composition of the controlled OUR feed is glucose.
10. The fermentation method for producing gentamicin by continuous fed-batch feeding with oxygen consumption rate as key control parameter as claimed in claim 1, wherein the primary seed culture medium composition (g/L): 1.4 parts of glucose, 15 parts of corn starch, 20 parts of corn flour, 2.6 parts of Angel peptone, 20 parts of low-temperature soybean flour, 2.5 parts of ammonium sulfate, 0.054 parts of potassium nitrate, 6.2 parts of calcium carbonate, 0.03 part of natural enemy, and 0.05 part of silicone oil, wherein the pH value is 7.2;
secondary seed medium (g/L): corn starch 23, corn flour 30, Angel peptone 13, bean cake powder 13, ammonium sulfate 5, magnesium sulfate 7.1, potassium nitrate 0.5, calcium carbonate 7, cobalt oxide 0.002, sodium chloride 0.05 and silicone oil 0.03, and pH 7.8;
fermentation basal medium (g/L): 50 parts of corn starch, 20 parts of corn flour, 25 parts of medium-temperature soybean flour, 23 parts of Angel peptone, 5 parts of ammonium sulfate, 7.1 parts of magnesium sulfate, 0.5 part of potassium nitrate, 7 parts of calcium carbonate, 0.002 part of cobalt oxide, 0.05 part of sodium alginate and 0.03 part of organic silicone oil, wherein the pH value is 9.0.
CN201910901442.6A 2019-09-23 2019-09-23 Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter Active CN110551783B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910901442.6A CN110551783B (en) 2019-09-23 2019-09-23 Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910901442.6A CN110551783B (en) 2019-09-23 2019-09-23 Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter

Publications (2)

Publication Number Publication Date
CN110551783A true CN110551783A (en) 2019-12-10
CN110551783B CN110551783B (en) 2021-07-06

Family

ID=68741141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910901442.6A Active CN110551783B (en) 2019-09-23 2019-09-23 Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter

Country Status (1)

Country Link
CN (1) CN110551783B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112029750A (en) * 2020-06-10 2020-12-04 华东理工大学 OUR-based fed-batch fermentation method for producing medium-temperature alpha-amylase by using bacillus subtilis
CN113930409A (en) * 2021-11-02 2022-01-14 华东理工大学 Method for efficiently producing Rhizomucor miehei lipase by aspergillus oryzae
CN115948622A (en) * 2022-09-22 2023-04-11 北京蓝晶微生物科技有限公司 Microbial fermentation control method, device, system, equipment and medium

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101560535A (en) * 2009-05-26 2009-10-21 浙江升华拜克生物股份有限公司 Process for producing abamectin by feeding glucose fermentation based on metabolizing parameters OUR
CN103642870A (en) * 2013-12-11 2014-03-19 河北欣港药业有限公司 Fermentation production method of rifamycin SV based on oxygen uptake rate OUR used as control parameter
CN104651431A (en) * 2014-12-26 2015-05-27 宁夏泰瑞制药股份有限公司 Culture medium and culture method for producing gentamicin by virtue of micromonospora fermentation
CN106801076A (en) * 2017-03-08 2017-06-06 河南仁华生物科技有限公司 A kind of process of fermenting and producing Gentamicin C1a
WO2017198793A1 (en) * 2016-05-18 2017-11-23 Katholieke Universiteit Leuven Automatical in situ control of the confined environment of metabolically active produce

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101560535A (en) * 2009-05-26 2009-10-21 浙江升华拜克生物股份有限公司 Process for producing abamectin by feeding glucose fermentation based on metabolizing parameters OUR
CN103642870A (en) * 2013-12-11 2014-03-19 河北欣港药业有限公司 Fermentation production method of rifamycin SV based on oxygen uptake rate OUR used as control parameter
CN104651431A (en) * 2014-12-26 2015-05-27 宁夏泰瑞制药股份有限公司 Culture medium and culture method for producing gentamicin by virtue of micromonospora fermentation
WO2017198793A1 (en) * 2016-05-18 2017-11-23 Katholieke Universiteit Leuven Automatical in situ control of the confined environment of metabolically active produce
CN106801076A (en) * 2017-03-08 2017-06-06 河南仁华生物科技有限公司 A kind of process of fermenting and producing Gentamicin C1a

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ZHANG DA-LI等: "Influence of dissolved oxygen and phosphate on the synthesis and secretion of gentamicin", 《ZHONGGUO KANGSHENGSU ZAZHI》 *
张鑫: "尾气在线分析在发酵过程控制与优化中的应用研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112029750A (en) * 2020-06-10 2020-12-04 华东理工大学 OUR-based fed-batch fermentation method for producing medium-temperature alpha-amylase by using bacillus subtilis
CN113930409A (en) * 2021-11-02 2022-01-14 华东理工大学 Method for efficiently producing Rhizomucor miehei lipase by aspergillus oryzae
CN115948622A (en) * 2022-09-22 2023-04-11 北京蓝晶微生物科技有限公司 Microbial fermentation control method, device, system, equipment and medium

Also Published As

Publication number Publication date
CN110551783B (en) 2021-07-06

Similar Documents

Publication Publication Date Title
CN110551783B (en) Fermentation method for producing gentamicin by using continuous flow feeding material with oxygen consumption rate as key control parameter
KR102174885B1 (en) Continuous culture of Aspergillus niger seeds and method for producing citric acid thereof
CN108285915B (en) Fermentation method of gibberellic acid
CN110846362B (en) Neomycin sulfate fermentation clean production method
CN111172086B (en) Fermentation method for producing L-isoleucine
CN112940945A (en) Method for fermenting hirsutella sinensis
CN104480174A (en) Culture medium for producing virginiamycin through streptomyces virginiae fermentation and feeding method of culture medium
CN101586133B (en) Abamectin batch fermentation optimizing process
CN102559794A (en) Lysine preparing method
CN111424058A (en) Method for preparing erythritol by adopting continuous fermentation mode
CN106854670B (en) Method for producing teicoplanin and regulating and controlling component content of teicoplanin by fermentation method
CN112852896A (en) Fermentation production method of L-arginine
CN111560414B (en) Fermentation medium for producing demethyl aureomycin
CN109628526B (en) Fermentation method for increasing yield of N-acetylglucosamine
CN114540437A (en) Method for producing long-chain dicarboxylic acid by biological fermentation
CN113755548A (en) Method for improving fermentation level of polymyxin B
CN112410395B (en) Feed medium for improving fermentation titer of 6-demethyltetracycline and application thereof
CN101012465B (en) Aminoglutaric acid fermentation production method for secondary inoculation superimposing bioepiderm
CN104232702A (en) Production method of lysine
CN110511974A (en) A kind of fermentation process improving abomacetin fermentation potency
CN111705092B (en) Feed supplement for improving fermentation titer of spectinomycin and preparation method and use method thereof
CN116622788B (en) Method for producing DHA by schizochytrium limacinum fermentation
CN112266946B (en) Mixed nitrogen source for tetracycline fermentation and application method thereof in tetracycline fermentation
CN113957115B (en) Fermentation method for high yield of gibberellic acid
CN114990178B (en) Method for improving quality of avilamycin fermentation liquor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant